Search results
Results from the WOW.Com Content Network
It was established in 2013 and is published exclusively online by Cell Press. It is the official journal of the International Society for Stem Cell Research. The editor-in-chief is Martin Pera (Jackson Laboratory). According to the Journal Citation Reports, the journal has a 2020 impact factor of 7.765. [1]
The 2016 Guidelines for Stem Cell Research and Clinical Translation Archived 2019-02-04 at the Wayback Machine have been adopted by researchers, clinicians, organizations, and institutions around the world. In 2013, the Society's official journal, Stem Cell Reports, was established; it is published monthly by Cell Press on the Society's behalf. [7]
The journal also publishes reviews covering basic, clinical, biotechnology, regulatory, and ethical aspects of stem cell research and applications. [1] The journal got its current name in 2009 from Stem Cell Reviews. According to Journal Citation Reports, the journal has a 2021 impact factor of 6.692. [2]
Stem-cell therapy uses stem cells to treat or prevent a disease or condition. [1] As of 2024, the only FDA-approved therapy using stem cells is hematopoietic stem cell transplantation. [2] [3] This usually takes the form of a bone marrow or peripheral blood stem cell transplantation, but the cells can also be derived from umbilical cord blood.
Primary hypertension, also known as essential hypertension, is the result of a consistent elevation of the force of blood being pumped throughout the body, whereas secondary hypertension is the result of high blood pressure due to another medical condition.> Diseases that can cause secondary hypertension include diabetic nephropathy, glomerular disease, polycystic kidney disease, cushing ...
Hypertension is also associated with decreased peripheral venous compliance, [77] which may increase venous return, increase cardiac preload and, ultimately, cause diastolic dysfunction. For patients having hypertension, higher heart rate variability (HRV) is a risk factor for atrial fibrillation. [78]
Stem cells therapy has been used to try to cure some of the damage caused by the body in MS. Hematopoietic stem cell transplantation has been used to try and cure MS patients by essentially "reprogramming" their immune system. The main risk encountered with this form of treatment is the possibility of rejection of the stem cells.
Induced pluripotent stem cells are similar to natural pluripotent stem cells, such as embryonic stem cells, in many aspects, such as the expression of certain stem cell genes and proteins, chromatin methylation patterns, doubling time, embryoid body formation, teratoma formation, viable chimera formation, and potency and differentiability, but ...